BL contributed to the acquisition and analysis of data, and drafting of the article
Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist licensed in the UK as Mounjaro for the treatment of type 2 diabetes mellitus and as Zepbound for weight management in adults with obesity (BMI 30 kg/m) or overweight (BMI 27 kg/m) with at least one weight-related comorbidity
Reports of acute kidney injury are almost always associated with not eating and drinking, says Drucker
You can make these more difficult by holding dumbbells at your side like two suitcases
Talk to your healthcare provider about getting a full metabolic panel, which should include tests like TSH, free T4, fasting insulin, HbA1c, and an androgen profile
Theyll be able to help you make the best decision for you